Emergence of vancomycin-resistant enterococci.

Rice, L. B.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Emergence of vancomycin-resistant enterococci.

Published Date:

2001 Mar-Apr

Source:

Emerg Infect Dis. 7(2):183-187.

[PDF-61.72 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Rice, L. B.

Description:

Vancomycin and ampicillin resistance in clinical Enterococcus faecium strains has developed in the past decade. Failure to adhere to strict infection control to prevent the spread of these pathogens has been well established. New data implicate the use of specific classes of antimicrobial agents in the spread of vancomycin-resistant enterococci (VRE). Extended-spectrum cephalosporins and drugs with potent activity against anaerobic bacteria may promote infection and colonization with VRE and may exert different effects on the initial establishment and persistence of high-density colonization. Control of VRE will require better understanding of the mechanisms by which different classes of drugs promote gastrointestinal colonization.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	11294702.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013–2018

Personal Author:

McCracken, Melissa; Mitchell, Robyn; Smith, Stephanie; Hota, Susy; Conly, John; Du, Tim; Embil, John; Johnston, Lynn; Ormiston, Debbie; Parsonage, Jennifer; Simor, Andrew; Wong, Alice; Golding, George;

Corporate Authors:

for the Canadian Nosocomial Infection Surveillance Program

Published Date:

Sep 2020

Source:

Emerg Infect Dis. 26(9):2247-2250

Description:

Rates of vancomycin-resistant enterococci bloodstream infections have remained relatively low in Canada. We recently observed an increase of 113% in these infections rates, which coincided with emergence of Enterococcus faecium pstS-null sequence typ...

File Type:

[PDF - 594.39 KB]
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.

Personal Author:

Huycke, M. M.; Sahm, D. F.; Gilmore, M. S.;

Published Date:

1998 Apr-Jun

Source:

Emerg Infect Dis. 4(2):239-249.

Description:

Enterococci, leading causes of nosocomial bacteremia, surgical wound infection, and urinary tract infection, are becoming resistant to many and sometimes all standard therapies. New rapid surveillance methods are highlighting the importance of examin...

File Type:

[PDF - 195.70 KB]
Diversity among multidrug-resistant enterococci.

Personal Author:

Murray, B. E.

Published Date:

1998 Jan-Mar

Source:

Emerg Infect Dis. 4(1):37-47.

Description:

Enterococci are associated with both community- and hospital-acquired infections. Even though they do not cause severe systemic inflammatory responses, such as septic shock, enterococci present a therapeutic challenge because of their resistance to a...

File Type:

[PDF - 66.33 KB]
Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization1

Personal Author:

Furuno, Jon P.; Perencevich, Eli N.; Johnson, Judith A.; Wright, Marc-Oliver; McGregor, Jessina C.; Morris, J. Glenn; Strauss, Sandra M.; Roghman, Mary-Claire; Nemoy, Lucia L.; Standiford, Harold C.; Hebden, Joan N.; Harris, Anthony D.;

Published Date:

Oct 2005

Source:

Emerg Infect Dis. 11(10):1539-1544.

Description:

We assessed the prevalence, risk factors, and clinical outcomes of patients co-colonized with vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) upon admission to the medical and surgical intensive care unit...

File Type:

[PDF - 162.87 KB]
Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Personal Author:

Kainer, Marion A.; Devasia, Rose A.; Jones, Timothy F.; Simmons, Bryan P.; Melton, Kelley; Chow, Susan; Broyles, Joyce; Moore, Kelly L.; Craig, Allen S.; Schaffner, William;

Published Date:

Jul 2007

Source:

Emerg Infect Dis. 13(7):1024-1030.

Description:

Linezolid was approved in 2000 for treatment of gram-positive coccal infections. We performed a case-control study during a hospital outbreak of linezolid-resistant enterococci (LRE) infections, comparing cases of LRE infection (cases) with linezolid...

File Type:

[PDF - 227.89 KB]